InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: lkashyap post# 16511

Wednesday, 12/26/2012 6:07:04 PM

Wednesday, December 26, 2012 6:07:04 PM

Post# of 403097
Do you think Harvards Dana Farber would risk their reputation to conduct a trial without seeing a substantial amount of data?

Plus, I don't believe the company is paying for much of this trial.



In Reply to 'lkashyap'
Again...I did...and as I said....anyone can start FDA Clinical trials...till you have money to do so....as it doesn't cost a penny to FDA...it costs to the company.....and as I have said previously....Lack of any Peer reviewed paper is quite unusual keeping their claims of targeting p53 both wild and mutant in mind...so I am assuming...even you dont have any PEER REVIEWED evidence to support their claims ?


KarinCAtrades.com

GLTA... KarinCA ;)

"Be kinder than necessary, for everyone you meet is fighting some kind of battle."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News